DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Bausch Health

Bausch Health

  • Q1 Pharma Sector Snapshot

    Q1 Pharma Sector Snapshot

  • COVID-19 Treatment and Vaccine Tracker This Document Contains an Aggregation of Publicly Available Information from Validated Sources

    COVID-19 Treatment and Vaccine Tracker This Document Contains an Aggregation of Publicly Available Information from Validated Sources

  • Companies in Attendance

    Companies in Attendance

  • Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Inc

    Valeant Pharmaceuticals International, Inc. 2012 Annual Report Valeant Inc

  • Fidelity® Select Portfolio® Pharmaceuticals Portfolio

    Fidelity® Select Portfolio® Pharmaceuticals Portfolio

  • Case 5:19-Cv-01087-OLG Document 55 Filed 05/07/20 Page 1 of 11

    Case 5:19-Cv-01087-OLG Document 55 Filed 05/07/20 Page 1 of 11

  • FDA Listing of Authorized Generics As of July 1, 2021

    FDA Listing of Authorized Generics As of July 1, 2021

  • Bausch Health Update – 3Q19 Seventh Consecutive Quarter of Total Company Organic Revenue Growth1,2

    Bausch Health Update – 3Q19 Seventh Consecutive Quarter of Total Company Organic Revenue Growth1,2

  • Rebateable Manufacturers

    Rebateable Manufacturers

  • SCHEDULE of INVESTMENTS (Unaudited) HEALTH CARE FUND

    SCHEDULE of INVESTMENTS (Unaudited) HEALTH CARE FUND

  • Current Sustaining Member Companies

    Current Sustaining Member Companies

  • Schedule of Investments Health Care Fund

    Schedule of Investments Health Care Fund

  • Current Sustaining Member Companies

    Current Sustaining Member Companies

  • Bausch Health 3Q20 Update: Recovery in Progress

    Bausch Health 3Q20 Update: Recovery in Progress

  • Current Sustaining Member Companies

    Current Sustaining Member Companies

  • MANUFACTURERS with CMS AGREEMENTS AS of 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY and COMPANY 00003 E.R

    MANUFACTURERS with CMS AGREEMENTS AS of 5-14-21 Labeler Code Labeler Name Program End Date 00002 ELI LILLY and COMPANY 00003 E.R

  • Download Current Complete HIN Authorized Licensee List

    Download Current Complete HIN Authorized Licensee List

  • Bausch Health – the Textbook Turnaround Giving Credit Where Credit Is Due – Target Price $40

    Bausch Health – the Textbook Turnaround Giving Credit Where Credit Is Due – Target Price $40

Top View
  • Bausch Health Companies Inc. Form 10-K Annual Report Filed 2019-02-20
  • Drug Formulary
  • 2020 Marketing Code of Conduct Compliant Companies
  • Current Sustaining Member Companies
  • Generic Pharma – Transaction Comps
  • MED-Project Participating Drug Companies - King County Washington, March 2020
  • Manufacturer's W/Start/End Dates and Sc Ind Appendix 1
  • Faculty Disclosures
  • The New Valeant: Delivering on Our Commitments J.P
  • Bausch Health 2019 Annual Report
  • In the United States District Court for the District of Delaware
  • Participating Vendor List October 2020
  • The Largest Pharmaceutical Companies Worldwide Analysis of Key Financial Indicators for Fiscal Years 2017, 2018 and 2019 About the Study
  • COVID-19 Vaccine Testing & Administration Guidance For
  • Patient Assistance Program Application
  • Valeant: an Enduring Engine for Growth
  • 20200915 MED-Project Participant List.Xlsx
  • View the Presentation


© 2024 Docslib.org    Feedback